NASDAQ: NTLA · Biotechnology
Over the past week, Intellia Therapeutics (NTLA) pulled in about 37 mentions across Reddit, X and news, and the read is an Adanos Buy. The crowd averages 69% bullish but is sharply divided: News runs 81% bullish while Reddit sits at just 50%. Wall Street is more cautious, with 10 of 19 analysts rating NTLA a buy.
There is little buzz around NTLA this week and little agreement on direction, which is why it reads as a Buy.
Wall Street’s 53% buy share sits next to a crowd that ranges from Reddit at 50% to News at 81%. No other tracker puts the two side by side.
19 analysts have weighed in: a Buy consensus: 10 buy calls against 3 sell, with an average 12-month price target of $23.94.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is a Buy.
The crowd runs 16 points hotter than the 53% analyst buy share, retail is ahead of the Street here. The split is inside the crowd: News reads 81% bullish while Reddit sits at 50%, a 31-point spread that single-source trackers miss.
Over the 30-day window, Intellia Therapeutics (NTLA) buzz held subdued around 39.3 while the price drifted up 1.0% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 3.3M shares. Updated Sep 10, 2026. Over the last 7 trading days, NTLA lost 4.1%. Buzz activity in the recent week averaged 35.6 and was variable, swinging between 22.7 and 51.4. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 17 of the 19 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for NTLA and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live NTLA sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 10, 2026.
| Adanos signal | Buy |
|---|---|
| Analyst consensus | Buy (10 / 6 / 3) |
| Crowd bullish (7d) | 69% |
| Avg price target | $23.94 |
| Most bullish source | News, 81% |
| Most bearish source | Reddit, 50% |
| Sentiment spread | 31 pts |
| Mentions (7d) | 37 |
| Market cap | $1.78B |
| EPS · Beta | -$3.32 · 1.8 |
| Revenue (TTM) | $59.5M · 0% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Intellia Therapeutics (NTLA) currently carries an Adanos buy signal with 93/100 conviction. The current cross-source average reads 69% bullish across 3 active sources. Those sources contribute 37 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Intellia Therapeutics (NTLA) is fairly quiet with 4 mentions over the last 7 days; the 30-day context spans 4 tracked subreddits. The 7-day tone is 50% bullish; 3-day activity momentum is falling, suggesting cooling attention.
The crowd reads bullish on Intellia Therapeutics (NTLA), averaging 69% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 81% bullish and Reddit at 50%, a 31-point spread. On the professional side, 10 of 19 analysts rate NTLA a buy.
Of the 19 analysts covering Intellia Therapeutics (NTLA), 10 rate it a buy, 6 a hold and 3 a sell, for a buy consensus. The average price target is $23.94. The crowd is the more bullish of the two, averaging 69%.
Intellia Therapeutics (NTLA)'s cross-source average is bullish at 69% bullish. Source readings are split: 2 sources lean bullish and 1 source sits at 50% bullish. X reads 75% bullish, News reads 81% bullish and reddit coverage is the most negative at 50% bullish. The combined signal points to broad buy-side pressure with 93/100 conviction.
The cross-source average is bullish for Intellia Therapeutics (NTLA) at 69% bullish. Source readings are split: 2 sources lean bullish and 1 source sits at 50% bullish. The most bearish reading is reddit at 50% bullish. 3-day activity momentum is falling on Reddit and X, while news activity is rising. The buy signal carries 93/100 conviction.
News is the dominant discussion channel with 21 mentions (57% of total volume). X contributes 12 mentions and Reddit contributes 4 mentions. The cross-source average is bullish at 69% bullish, while news is the only source with rising 3-day activity. Source readings are split: 2 sources lean bullish and 1 source sits at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. NTLA's buy signal at 93/100 conviction reflects a bullish cross-source average at 69% bullish. Source readings are split: 2 sources lean bullish and 1 source sits at 50% bullish. It is a research shortcut, not financial advice.
The NTLA sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Buy signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key